Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_17-cv-00663/USCOURTS-caed-1_17-cv-00663-2/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1441 Petition for Removal

---

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: LIPITOR (ATORVASTATIN CALCIUM)

MARKETING, SALES PRACTICES AND

PRODUCTS LIABILITY LITIGATION (NO. II) MDL No. 2502

(SEE ATTACHED SCHEDULE)

CONDITIONAL REMAND ORDER

The transferee court in this litigation has advised the Panel that coordinated or consolidated pretrial

proceedings in the action(s) on this conditional remand order have been completed and that remand

to the transferor court(s), as provided in 28 U.S.C. § 1407(a), is appropriate.

IT IS THEREFORE ORDERED that the action(s) on this conditional remand order be remanded to

its/their respective transferor court(s).

IT IS ALSO ORDERED that, pursuant to Rule 10.2 of the Rules of Procedure of the United States

Judicial Panel on Multidistrict Litigation, the transmittal of this order to the transferee clerk for

filing shall be stayed 7 days from the date of this order. If any party files a notice of opposition with

the Clerk of the Panel within this 7íday period, the stay will be continued until further order of the

Panel. This order does not become effective until it is filed in the office of the Clerk for the United

States District Court for the District of South Carolina.

IT IS FURTHER ORDERED that, pursuant to Rule 10.4(a), the parties shall furnish the Clerk for

the District of South Carolina with a stipulation or designation of the contents of the record to be

remanded.

FOR THE PANEL:

 Jeffery N. Lüthi

Clerk of the Panel

Case MDL No. 2502 Document 800 Filed 12/09/16 Page 1 of 2

Dec 09, 2016

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 1 of 5

$758(&23<

$77(6752%,1/%/80(&/(5.

%<

'(387<&/(5.

FILED

Jan 03, 2017

CLERK, U.S. DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

Case 1:17-cv-00663-LJO-MJS Document 24 Filed 01/03/17 Page 1 of 5
IN RE: LIPITOR (ATORVASTATIN CALCIUM)

MARKETING, SALES PRACTICES AND

PRODUCTS LIABILITY LITIGATION (NO. II) MDL No. 2502

SCHEDULE FOR CRO

TRANSFEREE TRANSFEROR

DIST DIV. C.A.NO. DIST DIV. C.A.NO. CASE CAPTION

SC 2 14í03235 CAC 2 14í03477 Jewel Williams et al v. Pfizer Inc. et al

SC 2 14í03173 CAC 2 14í05792 Kim Collins et al v. Pfizer Inc. et al

SC 2 14í03367 CAC 2 14í06226 Linda Watson et al v. Pfizer Inc. et al

SC 2 14í03592 CAC 2 14í06617 Helen Elliott et al v. Pfizer Inc. et al

SC 2 14í03894 CAC 2 14í07432 Eliane Scott et al v. Pfizer Inc. et al

SC 2 14í04060 CAC 2 14í07649 Bradley et al v. Pfizer Inc. et al

SC 2 14í04384 CAC 2 14í08261 Granieta JohnsoníWilson et al v. Pfizer Inc. et

al

SC 2 15í02377 CAC 2 15í01638 Robyn Whitney et al v. Pfizer Inc. et al

SC 2 14í03232 CAE 2 14í00818 Weaver v. Pfizer, Inc. et al

SC 2 14í03239 CAN 3 14í01488 Stark v. Pfizer et al

Case MDL No. 2502 Document 800 Filed 12/09/16 Page 2 of 2

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 2 of 5

Case 1:17-cv-00663-LJO-MJS Document 24 Filed 01/03/17 Page 2 of 5
2:14-cv-04060-RMG Date Filed 11/28/16 Entry Number 52 Page 1 of 3

Case MDL No. 2502 Document 800-1 Filed 12/09/16 Page 1 of 3

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 3 of 5

Case 1:17-cv-00663-LJO-MJS Document 24 Filed 01/03/17 Page 3 of 5
2:14-cv-04060-RMG Date Filed 11/28/16 Entry Number 52 Page 2 of 3

Case MDL No. 2502 Document 800-1 Filed 12/09/16 Page 2 of 3

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 4 of 5

Case 1:17-cv-00663-LJO-MJS Document 24 Filed 01/03/17 Page 4 of 5
2:14-cv-04060-RMG Date Filed 11/28/16 Entry Number 52 Page 3 of 3

Case MDL No. 2502 Document 800-1 Filed 12/09/16 Page 3 of 3

2:14-mn-02502-RMG Date Filed 12/09/16 Entry Number 1776 Page 5 of 5

Case 1:17-cv-00663-LJO-MJS Document 24 Filed 01/03/17 Page 5 of 5